Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

292 views

Visitors from

US 53%·

AU 34%·

IN 7%·

GB 2%·

HK 1%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Rushnet's Subsidiary heliosDX Commences National Marketing Campaign for Monkeypox Virus Testing Services

By: ACCESSWIRE

August 10, 2022 at 09:50 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ALPHARETTA, GA / ACCESSWIRE / August 10, 2022 / RushNet, Inc. (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX is reaching out across the U.S. to promote its services in collaboration with its lab partner for the Human Monkeypox Virus.

RushNet, Inc., Wednesday, August 10, 2022, Press release picture

heliosDX utilizes its CRM powered by SharpSpring to market the company and promote its services nationwide. The company is sending out a marketing campaign nationwide to promote its testing services for Human Monkeypox virus. This rising concern and increase in outbreaks has led heliosDX and its partner to act fast and to add PCR testing for the virus. The laboratory conducted test is available and the kits are ready for shipment.

As reported by the CDC, the virus has reached 9,492 cases in the US as of August 9th, 2022 with the hardest hit states being NY, CA, and then FL. For more information about the virus and national statistics visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
https://www.cdc.gov/poxvirus/monkeypox/symptoms.html

For our clinics and practices interested in fast and reliable PCR testing services for this virus and other illnesses please visit our website or contact us directly at 1-833-HELIOS8 (833-435-4678).

For quick access to our testing services, please visit the links below.

Customer account setup:
https://heliosdx.com/account-set-up-form/

Clinical Bulletin:
https://heliosdx.com/wp-content/uploads/2022/08/heliosDX_Clinical.pdf

Requisition form:
https://heliosdx.com/wp-content/uploads/2022/07/Infectious-Disease-PCR_7822.pdf

About HeliosDx:

heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, and Infectious Disease (PCR). We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. We intend to always stay ahead of the curve by continually investing in our infrastructure with the most efficient scientific proven instruments and latest cutting-edge software for patient and physician satisfaction. In management's opinion, following such best practices are intended to allow heliosDX to provide physicians fast and accurate reporting, meeting, and exceeding industry benchmarks. It is our goal to excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.

Contact:

Ashley Sweat
asweat@heliosdx.com
www.heliosdx.com
Twitter Handle: @dx_helios

About Grandeza Healthcare:

Grandeza Healthcare is a healthcare billing and consulting company. Providing expert billing and coding services to laboratories, medical practices, dental offices, and other medical verticals. In addition to billing, we provide Revenue Cycle Management (RCM) for all clients, as well as customized consulting services. We are a rapidly growing company adding new services and value to further demonstrate our competitive advantage.

Contact:

Danielle Bauer
dbauer@grandezahc.com
www.grandezahc.com
Twitter Handle: @GrandezaHC

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives

On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.

The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment, or other strategies with regard to COVID-19.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.

We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be averse to the pecuniary interests of the Company and of its shareholders.

SOURCE: RushNet, Inc.

View source version on accesswire.com:
https://www.accesswire.com/711558/Rushnets-Subsidiary-heliosDX-Commences-National-Marketing-Campaign-for-Monkeypox-Virus-Testing-Services

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	268.26	+0.00 (0.00%)
AAPL	280.14	+0.00 (0.00%)
AMD	360.54	+0.00 (0.00%)
BAC	53.24	+0.00 (0.00%)
GOOG	383.22	+0.00 (0.00%)
META	608.75	+0.00 (0.00%)
MSFT	414.44	+0.00 (0.00%)
NVDA	198.45	+0.00 (0.00%)
ORCL	171.83	+0.00 (0.00%)
TSLA	390.82	+0.00 (0.00%)